Clinical Trial Update: Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial [Phase 2, Phase 3]

View source ↗

Summary

A multicenter pilot randomized trial is evaluating anti-Xa guided dosing of low molecular weight heparin to prevent venous thromboembolism after traumatic injur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Alexandre Tran | Conditions: Venous Thromboembolism (VTE), Trauma Related Injuries | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING